Results

Total Results: 458 records

Showing results for "drug".

41. Study Finds Racial and Ethnic Inequities in End-of-Life Prescription Opioid Access | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/news/newsletters/e-newsletter/875.html
    August 01, 2023 - Disparities were also found in the frequency of drug screenings to gauge misuse of opioid medications … In addition, Black male patients were more likely be subject to urine drug screening, suggesting there … Between 2010 and 2021, the adoption rates surpassed 50 percent six months after Food and Drug Administration … Hospitalization due to adverse drug events in older adults with cancer: a retrospective analysis .

42. Biden Administration Tackles Financial Strains on Healthcare Consumers | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/news/blog/ahrqviews/financial-strains-healthcare.html
    November 01, 2023 - these price increases are misaligned incentives across the healthcare ecosystem, including soaring drug … For example, the Administration is pursuing Medicare initiatives to reduce drug spending.

43. Technical Specifications and Chart Abstraction Tool (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-200-tech-specs.pdf
    December 14, 2011 - sickle cell disease. 1: The addition of or an increase in a continuous infusion of any cardioactive drug … disease, unstable shock (the addition of or an increase in a continuous infusion of any cardioactive drug … : Unstable shock due to the addition of or an increase in a continuous infusion of any cardioactive drug … : Unstable shock due to the addition of or an increase in a continuous infusion of any cardioactive drug … "Unstable shock due to the addition of or an increase in a continuous infusion of any cardioactive drug

44. About AHRQ's Work on Opioids and Substance Use Disorders | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/opioids/about.html
    August 01, 2021 - About AHRQ's Work on Opioids and Substance Use Disorders Deaths from drug … The rise in drug overdose deaths was initially driven by misuse of prescription opioids but is now also

45. AHRQ Grantee Profiles | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/funding/grantee-profiles/index.html
    April 01, 2024 - More >> Protecting Patients from Drug-Drug Medication Errors Daniel C. Malone, Ph.D. … College of Pharmacy University of Utah “With funding from AHRQ, I’ve helped ensure that warnings for drug-drug

46. References | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/hai/pfp/hacrate2013-refs.html
    October 01, 2015 - Incidence of adverse drug events and potential adverse drug events. Implications for prevention. … Medication safety program reduces adverse drug events in a community hospital. … Adverse drug events among hospitalized patients: epidemiology and national estimates from a new approach … Adverse drug events in hospitalized patients. … Adverse drug events in U.S. hospitals, 2004. HCUP Statistical Brief #29.

47. Appendix 3: Data Abstraction (xls file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/ced-appendix3-data-abstraction.xlsx
    June 24, 2022 - Innovative Medicine Fund (UK) 14 National Insitute for Health and Care Excellence (NICE) Cancer Drug … Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1018-32. doi: 10.1002/pds.4295. PMID: 28913963. … and Biological Products Guidance for Industry US Food & Drug Administration. … and Biological Products US Food & Drug Administration. … and Biological Products US Food & Drug Administration.

48. Large-Scale Program To Reduce Heart Disease Risk Could Have Meaningful Health Benefits | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/news/newsletters/e-newsletter/857.html
    March 01, 2023 - COVID-19 Drug Does Not Impact Effectiveness of Anticoagulants . … COVID-19 Drug Does Not Impact Effectiveness of Anticoagulants Dexamethasone, a drug used to treat COVID

49. Library of PCOR Resources | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/pcor/library-of-resources/index.html
    April 01, 2021 - Background: ClinicalTrials.gov was created as a result of the Food and Drug Administration Modernization … Oregon Health and Science University's Drug Effectiveness Review Project ( DERP Clearinghouse [login … address gaps in knowledge, identifying the evidence to support VA performance measures, and rationalizing drug

50. Assessing the Availability of the Preconception Component of High-Risk Obstetrical Services by Estimating the Use of Teratogenic Medications Before and During Pregnancy (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-fullreport.pdf
    August 07, 2018 - Numerator Elements: Dated ICD-9 codes, DRGs, and prescription drug fill (or payment) data, including … NDC codes (National Drug Codes) or compound names. 1.H. … Prescription drug use during pregnancy is common. … Prescription drug use during pregnancy in developed countries: A systematic review. … Pharmacoepidemiol Drug Saf 2011; 20(9): 895-902. Diamond CC, Rask KJ, Kohler SA.

51. Data Infographics | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/data/infographics/index.html
    March 01, 2024 - All-Cause Readmissions for Septicemia More Opioid-Related Emergency Visits, No Change in Illicit Drug … Premiums for Employer-Sponsored Health Insurance Growing Pain of Spinal Stenosis Adverse Drug

52. Recent Data Analyses | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/opioids/data/analyses.html
    November 01, 2022 - More Opioid-Related Emergency Visits, No Change in Illicit Drug Use Treatment . September 2021. … Drug and Alcohol Dependence  2019 Jun; 199:151-158. doi: 10.1016/j.drugalcdep.2019.03.005

53. Section 1, Tables 1 and 2 (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-tables-1-2.pdf
    February 12, 2018 - hypotension) < 5th percentile for age or systolic BP < 2 SD below normal for age OR • Need for vasoactive drug

54. Section 1, Tables 1 and 2 (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-1-tables-1-2.pdf
    April 26, 2018 - hypotension) < 5th percentile for age or systolic BP < 2 SD below normal for age OR • Need for vasoactive drug

55. Section 1, Tables 1 and 2 (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-1-tables-1-2.pdf
    February 09, 2018 - ) < 5th percentile for age or systolic BP < 2 SD below normal for age OR • Need for vasoactive drug

56. New Data Resource Provides Insights on Factors Related to Falls | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/news/newsletters/e-newsletter/886.html
    October 01, 2023 - Adverse drug events caused by three high-risk drug-drug interactions in patients admitted to intensive

57. Translating CAHPS Surveys (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/translating-cahps-surveys.pdf
    January 17, 2017 - In the last 3 months, did you try to get information or help from your prescription drug plan’s … Since you joined your drug plan, how often did your drug plan’s customer service give you the information … Since you joined your drug plan, how often did your drug plan’s customer service treat you with … In the last 3 months, did you look for information from your drug plan about which prescription

58. Evidence for Practice | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/opioids/evidence.html
    November 01, 2023 - USPSTF Recommendation Statements related to substance use disorders include: Counseling for Illicit Drug … Unhealthy Drug Use: Screening .

59. Data Resources | Agency for Healthcare Research and Quality
    www.talkingquality.ahrq.gov/data/resources/index.html
    April 29, 2024 - Topics include infections (CDI and MRSA), adverse drug events (ADEs), and potentially avoidable injuries … Topics include depression, drug abuse, and eating disorders.

60. Final Data From National Efforts To Make Care Safer, 2010-2014 (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/2014FinalHACreport4Web-13Dec2016.pdf
    December 01, 2016 - About 40 percent of the overall reduction is from adverse drug events, about 28 percent from pressure … the deaths averted occurred as a result of reductions in the rates of pressure ulcers and adverse drug … , 2011-2014 16,760 7,922 4,403 2,750 26 42,716 1,692 1,150 1,768 7,746 Adverse Drug … $54,000,000 $10,030,000,000 $1,260,000,000 $168,000,000 $136,000,000 $2,907,000,000 Adverse Drug … , and Baseline Projections Made in 2011 on the Additional Inpatient Mortality per HAC Adverse Drug